全文获取类型
收费全文 | 2795篇 |
免费 | 205篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 29篇 |
儿科学 | 52篇 |
妇产科学 | 67篇 |
基础医学 | 449篇 |
口腔科学 | 63篇 |
临床医学 | 277篇 |
内科学 | 576篇 |
皮肤病学 | 33篇 |
神经病学 | 167篇 |
特种医学 | 138篇 |
外国民族医学 | 2篇 |
外科学 | 374篇 |
综合类 | 34篇 |
一般理论 | 1篇 |
预防医学 | 221篇 |
眼科学 | 45篇 |
药学 | 280篇 |
中国医学 | 2篇 |
肿瘤学 | 191篇 |
出版年
2021年 | 27篇 |
2020年 | 22篇 |
2019年 | 23篇 |
2018年 | 50篇 |
2017年 | 36篇 |
2016年 | 41篇 |
2015年 | 43篇 |
2014年 | 53篇 |
2013年 | 85篇 |
2012年 | 108篇 |
2011年 | 115篇 |
2010年 | 73篇 |
2009年 | 55篇 |
2008年 | 103篇 |
2007年 | 108篇 |
2006年 | 109篇 |
2005年 | 107篇 |
2004年 | 117篇 |
2003年 | 106篇 |
2002年 | 107篇 |
2001年 | 91篇 |
2000年 | 96篇 |
1999年 | 95篇 |
1998年 | 35篇 |
1997年 | 28篇 |
1996年 | 23篇 |
1992年 | 67篇 |
1991年 | 80篇 |
1990年 | 78篇 |
1989年 | 62篇 |
1988年 | 60篇 |
1987年 | 57篇 |
1986年 | 45篇 |
1985年 | 52篇 |
1984年 | 38篇 |
1983年 | 42篇 |
1982年 | 23篇 |
1981年 | 36篇 |
1979年 | 42篇 |
1978年 | 41篇 |
1977年 | 33篇 |
1976年 | 20篇 |
1975年 | 27篇 |
1974年 | 47篇 |
1973年 | 27篇 |
1972年 | 21篇 |
1971年 | 20篇 |
1970年 | 21篇 |
1969年 | 21篇 |
1967年 | 18篇 |
排序方式: 共有3001条查询结果,搜索用时 15 毫秒
41.
Kössel H Bartsch H Philippi W Unger M Bauer K Eyrich K Waldschmidt J Versmold HT 《Journal of pediatric surgery》1999,34(3):485-487
The treatment of a newborn with severe meconium aspiration by venoarterial extracorporeal membrane oxygenation (ECMO) was complicated by myocardial hypoxia with a marked decrease of myocardial contractility. The onset of the cardiac hypoxia was related to a pulmonary artery embolus. The origin of the embolus was a deep femoral vein thrombosis, caused by a central vein catheter, which was inserted 1 day before ECMO by venous cutdown. The possible pathophysiology of myocardial hypoxia in this patient is discussed, especially with regard to myocardial perfusion, supporting the hypothesis of coronary perfusion occuring with blood from the left ventricle and not from the arterial cannula in the aorta. 相似文献
42.
Identification of a clinically relevant immunodominant region of collagen IV in Goodpasture disease 总被引:3,自引:0,他引:3
Hellmark T Segelmark M Unger C Burkhardt H Saus J Wieslander J 《Kidney international》1999,55(3):936-944
BACKGROUND: The characteristic feature of Goodpasture disease is the occurrence of an autoantibody response to the noncollagenous domain of the alpha3 chain of type IV collagen [alpha3(IV)NC1] in the alveolar and glomerular basement membrane. These antibodies are associated with the development of a rapidly progressive glomerulonephritis, with or without lung hemorrhage, whereas autoantibodies specific for the other alpha chains of the heterotrimeric type IV collagen probably do not cause disease. In this study, we have investigated whether differences in fine specificity of autoimmune recognition of the alpha3(IV)NC1 correlate with clinical outcome. METHODS: For mapping of antibody binding to type IV collagen, chimeric collagen constructs were generated in which parts of the alpha3(IV)NC1 domain were replaced by the corresponding sequences of homologous nonreactive alpha1(IV). The different recombinant collagen chimeras allowed the analysis of antibody specificities in 77 sera from well-documented patients. RESULTS: One construct that harbors the aminoterminal third of the alpha3(IV)NC1 was recognized by all sera, indicating that it represents the dominant target of the B-cell response in Goodpasture disease. Seventy percent of the samples recognized other parts of the molecule as well. However, only reactivity to the N-terminus of the alpha3(IV)NC1 correlated with prognosis, that is, kidney survival after six months of follow-up. CONCLUSION: The results indicate the crucial importance of antibody recognition of this particular domain for the pathogenesis of Goodpasture disease, thereby opening new avenues for the development of better diagnostic and therapeutic procedures. 相似文献
43.
Culman J von Heyer C Piepenburg B Rascher W Unger T 《European journal of pharmacology》1999,367(2-3):255-265
Angiotensin AT1 receptor antagonists represent a novel class of cardiovascular drugs. In conscious, normotensive rats, irbesartan ((2-n-butyl-3-[(2'-(1H-tetrazol-5-yl)-biphenyl-4-yl) methyl]-1,3-diaza-spiro[4,4]non) and losartan ((2 n-butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl -4-yl) methyl] imidazol), two specific, high- affinity angiotensin AT1 receptor antagonists administered intravenously (i.v.) at doses of 0.3, 1, 3 and 10 mg/kg body weight, or orally (p.o.) at doses of 1, 3, 10 and 30 mg/kg body weight, antagonized the pressor responses to i.v. angiotensin II (50 ng/kg body weight) in a dose-related manner and with similar potency. In the following sets of experiments, we tested the hypothesis that these angiotensin AT1 receptor antagonists, when applied systemically, can inhibit the effects of angiotensin AT1 receptor stimulation in the brain. Irbesartan and losartan were administered i.v. or p.o. at doses of 3, 10, 30 and 100 mg/kg body weight. The responses to 100 ng angiotensin II injected into the lateral brain ventricle (i.c.v.), namely blood pressure increase, vasopressin release into the circulation and drinking, were recorded for up to 3 h. While both angiotensin AT1 receptor antagonists dose-dependently attenuated the pressor responses to central angiotensin AT1 receptor stimulation to a similar degree (maximal inhibition, irbesartan: 62% i.v., 39% p.o.; losartan: 62% i.v., 46% p.o.; respectively), irbesartan was more effective with respect to the inhibition of vasopressin release (76% i.v., 65% p.o.) and drinking (63% i.v., 79% p.o.) than losartan (58% i.v., 33% p.o and 22% i.v., 56% p.o., respectively). We conclude that systemically administered angiotensin AT1 receptor antagonists have access to central angiotensin receptors. The degree of central angiotensin AT1 receptor blockade following peripheral application may vary between different representatives of this class of drugs. 相似文献
44.
W Amberg S Hergenr?der H Hillen R Jansen G Kettschau A Kling D Klinge M Raschack H Riechers L Unger 《Journal of medicinal chemistry》1999,42(16):3026-3032
Structural variation of the endothelin A-selective antagonist (S)-3-methoxy-2-(4,6-dimethoxypyrimidin-2-yloxy)-3, 3-diphenylpropionic acid (LU 135252) led to analogues which retain ET(A) affinity but exhibit substantial ET(B) affinity as well. The most active derivative obtained is (S)-3-[2-(3, 4-dimethoxyphenyl)ethoxy]-2-(4,6-dimethylpyrimidin-2-yloxy)- 3, 3-diphenylpropionic acid (LU 302872), which can be prepared in enantiomerically pure form in eight steps via an acid-catalyzed transetherification. It has a K(i) = 2.15 nM for binding to the ET(A) receptor and a K(i) = 4.75 nM for binding to the ET(B) receptor, is orally available, and antagonizes the big ET-induced blood pressure increase in rats and the big ET-induced bronchospasm in guinea pigs each time at a dose of 10 mg/kg. 相似文献
45.
46.
P K Ghosh G Pohla-Gubo H Pohla H Antretter F Unger 《The Journal of cardiovascular surgery》1992,33(1):28-32
Serial estimation of total immunoglobulin E (IgE) concentration in 30 consecutive male patients undergoing coronary artery bypass grafting revealed three patterns--a low, middle and high response--during the perioperative period. The mean IgE level was higher in patients with higher mean preoperative left ventricular ejection fractions and these patients had a higher left ventricular stroke work index. However, there was no correlation with the severity of coronary artery disease or with degree of adequacy of revascularisation. Mean IgE level correlated moderately well with the mean right ventricular stroke work index and mean pulmonary capillary wedge pressure and minimally with the triple index. A higher level of IgE was usually observed with better cardiac performance and may be associated with factors related to the pulmonary circulation. However we could neither confirm nor refute whether an elevated level of IgE indicated an increased risk of cardiovascular events or a "protected status" against the complications of necrotising ischemia. 相似文献
47.
48.
Intravenous diltiazem versus nitroglycerin for silent and symptomatic myocardial ischemia in unstable angina pectoris 总被引:1,自引:0,他引:1
Z Y Fang N Picart M Abramowicz P Unger P Narracci J Sobolski G Berkenboom R Scheldewaert S Degré 《The American journal of cardiology》1991,68(12):42C-46C
For 18 patients consecutively admitted to the coronary care unit for unstable angina, 48-hour electrocardiographic Holter monitoring was performed after they were randomly assigned in a single-blind fashion to 1 of 2 treatment groups. The first group was treated with acetylsalicylic acid (ASA) and intravenous nitroglycerin, the second with ASA and intravenous diltiazem. All of the patients treated with nitroglycerin still had ischemic episodes after 48 hours (33% were symptomatic), in contrast with 11% of the diltiazem group (11% asymptomatic). Maximal ST-segment depressions of symptomatic and asymptomatic episodes were significantly different; and no significant increases in heart rate were observed either during the 15 seconds before ischemia began or during the ischemic episode. During the 48 hours, the diltiazem group had significantly fewer ischemic episodes (17) than did the nitroglycerin group (145). We concluded that "on-line" ST-segment observation is of prime importance for monitoring unstable angina; that the majority of the ischemic episodes associated with unstable angina are silent; and that intravenous diltiazem could be an effective pretreatment for patients who must undergo mechanical or surgical therapy. 相似文献
49.
50.